Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial
Lars Klareskog(Karolinska University Hospital), Marie Sanda, Saeed Fatenejad, Andrew Gough(Harrogate District Hospital), Michel Malaise(University of Liège), Karel Pavelká(Institute of Rheumatology), Désirée van der Heijde(Leiden University Medical Center), J Jäger(TAFE Queensland Gold Coast), Emilio Martín Mola(Hospital Universitario La Paz), Joachim R. Kalden(Friedrich-Alexander-Universität Erlangen-Nürnberg), L. Settas(AHEPA University Hospital), J Sany(Hôpital Lapeyronie), Ronald Pedersen, Joseph Wajdula
Cited by 1,770
Related Papers
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
|Pharmacology & Therapeutics|2007|1.6k
A new model for an etiology of rheumatoid arthritis: Smoking may trigger HLA–DR (shared epitope)–restricted immune reactions to autoantigens modified by citrullination
|Arthritis & Rheumatism|2005|1.5k
EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis
|Annals of the Rheumatic Diseases|2013|1.4k
<i>STAT4</i> and the Risk of Rheumatoid Arthritis and Systemic Lupus Erythematosus
|New England Journal of Medicine|2007|1.1k
Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis
|Nature Biotechnology|2013|1k